1. What is the projected Compound Annual Growth Rate (CAGR) of the Blood Banking?
The projected CAGR is approximately 7%.
+1 2315155523
MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
Blood BankingBlood Banking by Type (/> Blood Collection Devices, Blood Processing Devices, Blood Storage Devices), by Application (/> Hospitals, Blood Center), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2026-2034
The global blood banking market is projected to experience significant expansion, propelled by the rising incidence of chronic diseases necessitating transfusions, escalating demand for blood components in surgical and trauma procedures, and continuous technological innovation in blood collection, processing, and storage. Enhanced public awareness regarding blood donation and supportive government initiatives aimed at improving blood bank infrastructure, especially in emerging economies, are further accelerating market growth. Despite challenges in supply chain efficiency and blood safety amidst rising healthcare expenditures, the market is on a trajectory for substantial growth. The market is estimated at $19.18 billion in the base year of 2025, with a projected Compound Annual Growth Rate (CAGR) of 7% through 2033. This expansion is largely driven by an aging global population, increasing the demand for blood products. Advancements in technologies like automated blood component separation and enhanced blood storage solutions are also contributing by boosting efficiency and extending product shelf life.
Geographically, North America dominates the market due to its robust healthcare infrastructure and high per capita spending. However, the Asia-Pacific region, particularly China and India, is experiencing rapid growth fueled by demographic shifts and increased healthcare investments. Europe remains a crucial market, characterized by established players and advanced technologies. The competitive environment features a blend of large multinational corporations and regional entities, including non-profit organizations like the Red Cross, fostering innovation and competition. Strategic collaborations, mergers, and acquisitions are anticipated to shape market dynamics throughout the forecast period.
The global blood banking market is experiencing significant growth, projected to reach tens of billions of units by 2033. The market's expansion is driven by several converging factors, including an increasing global population, rising prevalence of chronic diseases requiring blood transfusions (like cancer and cardiovascular diseases), and advancements in blood collection, processing, and storage technologies. Over the historical period (2019-2024), the market demonstrated steady expansion, with particular acceleration noted in regions with developing healthcare infrastructures. The estimated market value in 2025 reflects a substantial increase from the base year, indicating a strong upward trajectory. This growth is further fueled by the increasing awareness of the importance of blood donation and improved blood safety regulations globally. The forecast period (2025-2033) anticipates continued expansion, though the rate of growth may vary depending on factors such as economic conditions and public health initiatives. Key market insights reveal a shift towards automated and technologically advanced systems for blood processing, a growing demand for pathogen-reduced blood components, and an increasing focus on personalized medicine approaches within blood transfusion practices. The market is also seeing a greater emphasis on efficient supply chain management to reduce wastage and ensure timely delivery of blood products to hospitals and clinics. Competition among leading players is intensifying, prompting innovation in product development and service offerings. The market is also witnessing the rise of personalized medicine, with tailored blood products becoming increasingly important. Finally, the growing adoption of digital technologies is transforming various aspects of blood banking, from inventory management to donor recruitment.
Several key factors are propelling the growth of the blood banking market. Firstly, the ever-increasing global population necessitates a corresponding increase in the demand for blood and blood products. Secondly, the rising incidence of chronic diseases, accidents, and surgical procedures requiring blood transfusions is a significant driver. The aging global population, particularly in developed nations, contributes to this increased demand. Simultaneously, advancements in medical technology and the development of new therapies often necessitate blood products, further stimulating market growth. Improved diagnostic tools have also led to earlier detection and treatment of conditions requiring blood transfusions. Furthermore, increasing government initiatives and public awareness campaigns focused on promoting blood donation are contributing to a more readily available blood supply. Investment in research and development is yielding innovative technologies that enhance blood collection, processing, storage, and testing procedures, ultimately improving safety and efficiency. This innovation is a key factor in expanding the market's overall potential. Finally, the growing adoption of stringent blood safety regulations and quality control measures across various regions is promoting better blood management practices and boosting market confidence.
Despite the considerable growth potential, the blood banking market faces several challenges. One major obstacle is the persistent shortage of blood donations globally. Maintaining a sufficient supply of blood remains a significant logistical and organizational hurdle, particularly in regions with limited healthcare resources or low public awareness of the importance of blood donation. Another significant constraint is the high cost of blood collection, processing, testing, storage, and transportation, particularly for specialized blood components. This cost can pose a barrier to access for some healthcare facilities and patients. Furthermore, maintaining the quality and safety of blood products throughout the entire supply chain presents numerous logistical and technological challenges. Stringent regulations and quality control measures are necessary, but also add to the overall cost and complexity of the process. The risk of blood-borne infections and the need for meticulous testing and screening contribute to operational costs and add to the overall complexity of the industry. Finally, the potential for blood wastage due to inadequate storage facilities, improper handling, or inefficient supply chain management further complicates the situation, emphasizing the need for robust infrastructure and optimized procedures.
The North American blood banking market, particularly the United States, is expected to dominate the global market during the forecast period due to factors like well-established healthcare infrastructure, high prevalence of chronic diseases, high adoption rate of advanced technologies, and strong regulatory support. Within this region, the blood collection devices segment is anticipated to maintain a leading position due to continuous technological advancements in automated and efficient blood collection systems. Hospitals remain the primary end-users, consuming a large percentage of blood products.
The substantial growth forecast underscores the growing necessity for efficient, safe, and reliable blood banking systems across the globe.
Several key factors are acting as growth catalysts for the blood banking industry. The continuous advancement of blood collection, processing, and storage technologies is significantly improving efficiency, safety, and the overall quality of blood products. Increased public awareness campaigns and governmental initiatives aimed at promoting blood donation are generating a more substantial blood supply. Furthermore, the growing prevalence of chronic diseases requiring blood transfusions is driving demand. Finally, the expanding global population ensures a continuing need for a robust and reliable blood banking system.
This report offers a detailed analysis of the global blood banking market, covering key trends, drivers, challenges, and growth prospects from 2019 to 2033. It provides insights into market segmentation, leading players, and significant developments. The report uses reliable data and forecasts to provide a comprehensive overview of this crucial sector, offering valuable information for stakeholders across the blood banking ecosystem.
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 7% from 2020-2034 |
| Segmentation |
|
Note*: In applicable scenarios
Primary Research
Secondary Research
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
The projected CAGR is approximately 7%.
Key companies in the market include Abbott Laboratories(USA), American Red Cross(USA), America’s Blood Centers(USA), Beckman Coulter, Inc.(USA), Becton, Dickinson and Company(USA), Bio Products Laboratory Ltd.(UK), Bio-Rad Laboratories, Inc.(USA), bioMérieux SA(France), Biotest AG(Germany), Canadian Blood Services(Canada), Cerus Corporation(USA), China Biologic Products, Inc.(China), CSL Behring LLC(USA), Fenwal Inc.(USA), Fresenius Kabi AG(Germany), Grifols S.A.(Spain), Haemonetics Corporation(USA), Huanlan Biological Engineering Inc.(China), Immucor Inc.(USA), Japan Red Cross Society(Japan), Kawasumi Laboratories, Inc.(Japan), Kedrion S.p.A.(Italy), MacoPharma SA(France), New York Blood Center(USA), Octapharma AG(Switzerland), Ortho-Clinical Diagnostics, Inc.(USA), Shanghai RAAS Blood Products Co., Ltd.(China), Shire plc(Ireland), Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.(China), Terumo BCT Inc.(USA).
The market segments include Type, Application.
The market size is estimated to be USD 19.18 billion as of 2022.
N/A
N/A
N/A
N/A
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4480.00, USD 6720.00, and USD 8960.00 respectively.
The market size is provided in terms of value, measured in billion.
Yes, the market keyword associated with the report is "Blood Banking," which aids in identifying and referencing the specific market segment covered.
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
To stay informed about further developments, trends, and reports in the Blood Banking, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.